Financials data is unavailable for this security.
View more
Year on year Creo Medical Group PLC grew revenues 13.36% from 27.17m to 30.80m while net income improved from a loss of 26.94m to a smaller loss of 21.70m.
Gross margin | 49.68% |
---|---|
Net profit margin | -70.45% |
Operating margin | -80.52% |
Return on assets | -28.56% |
---|---|
Return on equity | -39.74% |
Return on investment | -34.84% |
More ▼
Cash flow in GBPView more
In 2023, cash reserves at Creo Medical Group PLC fell by 10.10m. Cash Flow from Financing totalled 29.80m or 96.75% of revenues. In addition the company used 21.60m for operations while cash used for investing totalled 18.30m.
Cash flow per share | -0.0585 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.1655 |
---|---|
Tangible book value per share | 0.093 |
More ▼
Balance sheet in GBPView more
Current ratio | 3.83 |
---|---|
Quick ratio | 3.01 |
Total debt/total equity | 0.1388 |
---|---|
Total debt/total capital | 0.1219 |
More ▼